Does Your Spouse Influence Your DTC Viewing Experience? FDA Wants to Peek Into Your Bedroom
FDA’s Office of Prescription Drug Promotion (OPDP) plans to examine differences between consumers viewing prescription drug ads with a spouse versus alone.
In its Federal Register notice about the “Spousal Influence” study (“Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements”; FDA-2014-N-1819), FDA presented this premise:
“Judgments about prescription drugs portrayed in DTC ads are likely made in social contexts much of the time. For example, a potential consumer and his or her spouse (e.g., marital or domestic partner) may view an ad together and discuss drug benefits, side effects, and risks. These social interactions may result in unique reactions relative to consumers who view DTC prescription drug ads alone.”
This article is a review of that study.
Topics include (partial list):
- Study Design
- A Missed Opportunity
- Impact on Regulation of Ads
- A Viagra Ad Your Spouse May Not Want You to See
Download the full text PDF file here:
www.pharma-mkting.com/news/pmnews1310-article03.pdf
#FDA Needs to Do a Better Job Communicating DTC Research Results, Says Expert
PMN1310-03
Issue: Vol. 13, No. 10: December 2014
